The clinical trials below are available in the specialty you selected. Choose a different specialty.

Sunitinib Plus Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer after Failure of Docetaxel Chemotherapy
Men with metastatic hormone-refractory prostate cancer are needed to participate in a research trial. (REF# 11630)

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology in Men with Castration-Resistant Metastatic Prostate Cancer
Men with castration-resistant metastatic prostate cancer are needed for a research study. (REF# 16256)

Abiraterone Acetate Plus Prednisone Versus Placebo Plus Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer (Cougar 302)
Men with mildly symptomatic metastatic castration-resistant prostate cancer are needed for research study. (REF# 16572)

Sipuleucel-T in Men with Metastatic, Castrate-Resistant Prostate Cancer
Men with metastatic, castrate-resistant prostate cancer are needed for this study. (REF# 17992)

Docetaxel Plus Dasatinib Versus Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
Men with castration-resistant prostate cancer are needed for a clinical trial. (REF# 13476)

ZD4054 Plus Docetaxel Versus Placebo Plus Docetaxel in Patients with Metastatic Hormone-Resistant Prostate Cancer
Men with prostate cancer are needed for a clinical trial examining the effectiveness of a new drug. (REF# 4793)

Prostate Cancer Recovery Enhancement for African American Men and Their Intimate Partners
The PROCARE study will evaluate two educational interventions tailored for African American prostate cancer survivors and their intimate partners. (REF# 3525)

Prospective Validation of a Microarray-Based Docetaxel Response Signature in Metastatic, Hormone-Refractory Prostate Cancer
This is a study to determine if a microarray-based docetaxel response signature can accurately predict response to docetaxel chemotherapy in men with metastatic, hormone refractory prostate cancer (HRPC). (REF# 11890)

Coping Skills Training Groups to Enhance Recovery from Prostate Cancer in African American Men
The CAAPS Study (Coping in African American Prostate Cancer Survivors), is a randomized clinical trial being conducted at Duke University to evaluate two educational group interventions tailored for African American prostate cancer survivors. (REF# 351)